RecruitingNCT06307184

Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer

Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer: an Ambispective Cohort Study


Sponsor

Instituto Valenciano de Infertilidade de Lisboa

Enrollment

530 participants

Start Date

Feb 23, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study will assess the convenience of the natural proliferative phase frozen embryo transfer (NPP-FET) in terms of number of number of appointments needed before cycle scheduling.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 49 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Natural proliferative phase frozen embryo transfer for people with frozen embryo transfer. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 49 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURENatural proliferative phase frozen embryo transfer

When endometrial thickness is above 7 mm, vaginal micronized progesterone will be administered 400mg 12/12h when the dominant follicle is at least 13 mm, serum estradiol (E2) levels are \>80 pg/ml, and serum progesterone levels are \<1.5ng/ml. Embryo transfer will be performed on the fifth day of progesterone.


Locations(1)

Instituto Valenciano de Infertilidade

Lisbon, Portugal

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06307184


Related Trials